|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2006.01) |
| A61K 31/712 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 2563920 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11778071.8 |
| Date of filing the European patent application | 2011-04-29 | |
| (97) | Date of publication of the European application | 2013-03-06 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-15 |
| (46) | Date of publication of the claims translation | 2017-05-25 |
| (86) | Number | PCT/US2011/034661 |
| Date | 2011-04-29 |
| (87) | Number | WO 2011/139917 |
| Date | 2011-11-10 |
| (30) | Number | Date | Country code |
| 405163 P | 2010-10-20 | US | |
| 329538 P | 2010-04-29 | US |
| (72) |
MONIA, Brett, P., US
FREIER, Susan, M., US
SIWKOWSKI, Andrew, M., US
|
| (73) |
Ionis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Transtiretino raiškos moduliavimas |
| MODULATION OF TRANSTHYRETIN EXPRESSION |
| Payment date | Validity (years) | Amount | |
| 2026-03-19 | 16 | 347.00 EUR |
| 2027-04-29 |